'Undruggable' oncogene inhibited in promising cancer trial
03 November, 2020A novel agent that targets a mutated form of the KRAS gene — the most commonly altered oncogene in human cancers — shrank tumours in most patients in a clinical trial.
Steroid boosts survival of premmies in low-resource settings
02 November, 2020Dexamethasone can boost survival of premature babies when given to pregnant women at risk of preterm birth in low-resource settings.
Anticancer candidate inhibits drug-induced hyperglycaemia
26 October, 2020A new anticancer drug candidate offers a way to inhibit both tumour growth and drug-induced hyperglycaemia in multiple models of HR+ breast cancer.
Disappointing results for WHO's COVID-19 therapeutics trial
21 October, 2020 by Lauren DavisInterim results indicate that the four treatments tested appear to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalised patients.
Single daily pill for Parkinson's disease developed
06 October, 2020Scientists have developed a pill which uses the stomach as a drug reservoir and delivers medicines slowly over time to patients with Parkinson's disease.
Diabetes drug benefits cognition, pregnancy outcomes
29 September, 2020Metformin could be particularly beneficial for people with type 2 diabetes who are older or looking to become pregnant, as discovered by two separate studies.
TGA approves gene therapy to treat retinal disease
25 September, 2020The TGA has registered Novartis's LUXTURNA, the first gene therapy in Australia, for the treatment of patients with inherited retinal dystrophy.
Aus Govt joins COVAX, funds more local COVID-19 vaccines
23 September, 2020The Australian Government has joined the COVAX facility, enabling the purchase of COVID-19 vaccine doses as they become available.
Combining precision medicines can treat drug-resistant cancers
22 September, 2020Launching a dual-pronged attack on tumours using a combination of two precision medicines could treat patients with multiple common cancers.
Cytiva Xcellerex Automated Perfusion System (APS)
21 September, 2020The system's automation capabilities include automated filter switching, liquid management and cell bleed, reducing risk for human error and increasing process robustness.
Cortical vision device could restore sight to the blind
18 September, 2020The bionic vision system makes it possible to treat many conditions that currently have treatment limitations, thanks to the use of electronic implants that sit on the surface of the brain.
Steroids improve outcomes for severe COVID-19 infections
16 September, 2020Studies of critically ill patients with COVID-19 show that fewer patients died and less ICU support was required when patients received corticosteroids.
Drug improves bone growth in children with dwarfism
11 September, 2020A phase 3 clinical trial has shown that a new drug boosts bone growth in children born with achondroplasia — the most common type of dwarfism.
CSL agrees to manufacture COVID-19 vaccines for Australia
09 September, 2020Biotech company CSL has signed two separate heads of agreement (HoA) for COVID-19 vaccines should clinical trials prove successful.
Honeybee venom kills aggressive breast cancer cells
03 September, 2020 by Lauren DavisVenom from honeybees has been found to induce cancer cell death in hard-to-treat triple-negative breast cancer, with minimal effect on healthy cells.
